MPMarisol Perez-Toledo

Marisol Perez-Toledo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marisol Perez-Toledo has a total of 206 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Vaccine-induced antibodies can limit Salmonella infection in the absence of complement or macrophages

    by Marisol Perez-Toledo, Kubra Aksu-Istil, Edith Marcial-Juarez, Ruby R. Persaud, Areej Alshayea, Sian E. Jossi, Agostina Carestia, Fien von Meijenfeld, Marina Botto, Leo C. James, et al.

    Antibodies against Salmonella Typhimurium (STm) can provide protection against infection. Understanding how antibodies, complement, and leukocytes interact is essential and can help advance vaccine development. To evaluate the in vivo role of STm-specific antibodies, mice were immunized with an outer membrane vesicle (OMV) vaccine and subsequently challenged with STm. Immunohistology and intravital microscopy revealed that OMV-induced antibodies promoted STm uptake by macrophages in the spleen and liver, whereas bacteria were only infrequently associated with neutrophils. Depletion of monocytic cells using clodronate liposomes demonstrated that these cells help prevent antigen dissemination. Immunization and challenge experiments in mice deficient in C1q, C3, C4, or C5 showed that OMV immunization conferred protection in all groups except C3-deficient mice. Mice deficient in C3 failed to develop robust germinal center and plasma cell responses following OMV immunization. Nevertheless, C3-deficient mice that received immune sera by adoptive transfer prior to infection had significantly reduced bacterial burdens compared to mice receiving non-immune control sera. In vitro studies using human sera and THP-1 cells confirmed that antibodies alone are sufficient to promote bacterial capture by macrophages. Complement—particularly C1q and C3, but not C5—further enhanced bacterial uptake. Overall, under the conditions tested, antibodies are sufficient to reduce STm burdens in vivo and facilitate bacterial uptake in vitro , with these processes supported by complement and macrophages. IMPORTANCE: Bacterial infections remain a significant global challenge, further complicated by the growing issue of antimicrobial resistance (AMR). In this context, vaccination provides a cost-effective means of preventing infections and combating the emergence of AMR strains. Antibodies are key mediators of vaccine-induced protection. However, their mechanisms of action in vivo are not fully understood. In this study, we demonstrate how antibodies enhance the capture of Salmonella by macrophages. Although these cells may be dispensable for controlling bacterial numbers, they are crucial for limiting the spread of bacterial antigens. Additionally, we find that the classical complement cascade is not necessary for bacterial clearance but does facilitate bacterial capture by macrophages. Overall, our findings reveal that multiple antibody-mediated pathways operate in vivo , exhibiting some redundancy in their combined efforts to control infection, underscoring the importance of antibody functions in limiting bacterial spread.


  • Open Access

    Discrete and conserved inflammatory signatures drive thrombosis in different organs after Salmonella infection

    by Marisol Perez-Toledo, Nonantzin Beristain-Covarrubias, Jamie Pillaye, Ruby R. Persaud, Edith Marcial-Juarez, Sian E. Jossi, Jessica R. Hitchcock, Areej Alshayea, William M. Channell, Niek T. J. Wiersma, et al.

    Inflammation-induced thrombosis is a common consequence of bacterial infections, such as those caused by Salmonella Typhimurium (STm). The presentation of multi-organ thrombosis post-infection that develops and resolves with organ-specific kinetics raises significant challenges for its therapeutic control. Here, we identify specific inflammatory events driving thrombosis in the spleens and livers of STm-infected mice. IFN-γ or platelet expression of C-type lectin-like receptor CLEC-2, key drivers of thrombosis in liver, are dispensable for thrombosis in the spleen. Platelets, monocytes, and neutrophils are identified as core constituents of thrombi in both organs. Depleting either neutrophils or monocytic cells abrogates thrombus formation. Neutrophils and monocytes secrete TNF and blocking TNF diminishes both thrombosis and inflammation, which correlates with reduced endothelial expression of E-selectin and leukocyte infiltration. Moreover, inhibiting tissue factor and P-selectin glycoprotein ligand-1 pathways impairs thrombosis in both spleen and liver. Therefore, we identify organ-specific, and shared mechanisms driving thrombosis within a single infection. This may inform on tailoring treatments towards infection-induced inflammation, and single- or multi-organ thrombosis, based on the clinical need.


  • Open Access

    Distinct Neutralising and Complement-Fixing Antibody Responses Can Be Induced to the Same Antigen in Haemodialysis Patients After Immunisation with Different Vaccine Platforms

    by Nadezhda Wall, Rachel Lamerton, Fiona Ashford, Marisol Perez-Toledo, Aleksandra Jasiulewicz, Gemma D. Banham, Maddy L. Newby, Sian E. Faustini, Alex G. Richter, Haresh Selvaskandan, et al.

    Background/Objectives: Generalised immune dysfunction in chronic kidney disease, especially in patients requiring haemodialysis (HD), significantly enhances the risk of severe infections. Vaccine-induced immunity is typically reduced in HD populations. The SARS-CoV-2 pandemic provided an opportunity to examine the magnitude and functionality of antibody responses in HD patients to a previously unencountered antigen—Spike (S)-glycoprotein—after vaccination with different vaccine platforms (viral vector (VV); mRNA (mRV)). Methods: We compared the total and functional anti-S antibody responses (cross-variant neutralisation and complement binding) in 187 HD patients and 43 healthy controls 21–28 days after serial immunisation. Results: After 2 doses of the same vaccine, HD patients had anti-S antibody levels and a complement binding capacity comparable to controls. However, 2 doses of mRV induced greater polyfunctional antibody responses than VV (defined by the presence of both complement binding and cross-variant neutralisation activity). Interestingly, an mRV boost after 2 doses of VV significantly enhanced antibody functionality in HD patients without a prior history of SARS-CoV-2 infection. Conclusions: HD patients can generate near-normal, functional antigen-specific antibody responses following serial vaccination to a novel antigen. Encouragingly, exploiting immunological memory by using mRNA vaccines and boosting may improve the success of vaccination strategies in this vulnerable patient population.


  • Open Access

    Platelet aggregation responses to Salmonella Typhimurium are determined by host anti- Salmonella antibody levels

    by Rachel E Lamerton, Samantha J Montague, Marisol Perez-Toledo, Steve P Watson, Adam F Cunningham

    Invasive non-typhoidal Salmonella infections are responsible for >75 000 deaths/year and >500 000 cases/year globally. Seventy-five percent of these cases occur in Sub-Saharan Africa, an increasing number of which are from multi-drug resistant strains. Interactions between bacteria and platelets can lead to thrombus formation, which can be beneficial for control of infection (immunothrombosis), or harmful through uncontrolled inflammation and organ damage (thromboinflammation). It is unknown whether Salmonella Typhimurium can activate human platelets. To assess this, light transmission aggregometry was used to measure platelet activation by two different Salmonella Typhimurium strains in 26 healthy donors in platelet-rich plasma and washed platelets. In platelet-rich plasma, but not in washed platelets, Salmonella Typhimurium activated platelets in a donor- and strain-dependent manner mediated through the low affinity immune receptor FcγRIIA and the feedback agonists, ADP and thromboxane A2. Plasma swap studies between strong and weak responders demonstrated a plasma component was responsible for the variation between donors. Depletion of anti-Salmonella antibodies from plasma abolished Salmonella-induced platelet aggregation responses, and addition of polyclonal anti-Salmonella antibody allowed aggregation in washed platelets. Correlating levels of anti-Salmonella total IgG or the IgG1, IgG2, IgG3 and IgG4 subclasses to platelet responses revealed total IgG levels, rather than levels of individual subclasses, positively correlated with maximum platelet aggregation results, and negatively with lag times. Overall, we show that anti-Salmonella IgG antibodies are responsible for donor variation in platelet aggregation responses to Salmonella and mediate this activity through FcγRIIA.


  • Open Access

    Discrete and conserved inflammatory signatures drive thrombosis in different organs after Salmonella infection

    by Marisol Perez-Toledo, Nonantzin Beristain-Covarrubias, Jamie Pillaye, Ruby R Persaud, Edith Marcial-Juarez, Sian E. Jossi, Jessica R. Hitchcock, Areej Alshayea, William M. Channell, Rachel E Lamerton, et al.

    Inflammation-induced thrombosis is a common consequence of bacterial and viral infections, such as those caused by Salmonella Typhimurium (STm) and SARS-CoV-2. The identification of multi-organ thrombosis and the chronological differences in its induction and resolution raises significant challenges for successfully targeting multi-organ infection-associated thrombosis. Here, we identified specific pathways and effector cells driving thrombosis in the spleen and liver following STm infection. Thrombosis in the spleen is independent of IFN-γ or the platelet C-type lectin-like receptor CLEC-2, while both molecules were previously identified as key drivers of thrombosis in the liver. Furthermore, we identified platelets, monocytes, and neutrophils as core constituents of thrombi in both organs. Depleting neutrophils or monocytic cells independently abrogated thrombus formation. Nevertheless, blocking TNFα, which is expressed by both myeloid cell types, diminished both thrombosis and inflammation which correlates with reduced endothelial expression of E-selectin and leukocyte infiltration. Moreover, tissue factor and P-selectin glycoprotein ligand 1 inhibition impair thrombosis in both spleen and liver, identifying multiple common checkpoints to target multi-organ thrombosis. Therefore, organ-specific, and broad mechanisms driving thrombosis potentially allow tailored treatments based on the clinical need and to define the most adequate strategy to target both thrombosis and inflammation associated with systemic infections.

  • Open Access

    Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses

    by Siân E. Jossi, Melissa Arcuri, Areej Alshayea, Ruby R. Persaud, Edith Marcial-Juárez, Elena Palmieri, Roberta Di Benedetto, Marisol Pérez-Toledo, Jamie Pillaye, Will M. Channell, et al.

    Vaccination with Vi capsular polysaccharide (Vi-PS) or protein-Vi typhoid conjugate vaccine (TCV) can protect adults against Salmonella Typhi infections. TCVs offer better protection than Vi-PS in infants and may offer better protection in adults. Potential reasons for why TCV may be superior in adults are not fully understood. Here, we immunized wild-type (WT) mice and mice deficient in IgG or IgM with Vi-PS or TCVs (Vi conjugated to tetanus toxoid or CRM 197 ) for up to seven months, with and without subsequent challenge with Vi-expressing Salmonella Typhimurium. Unexpectedly, IgM or IgG alone were similarly able to reduce bacterial burdens in tissues, and this was observed in response to conjugated or unconjugated Vi vaccines and was independent of antibody being of high affinity. Only in the longer-term after immunization (>5 months) were differences observed in tissue bacterial burdens of mice immunized with Vi-PS or TCV. These differences related to the maintenance of antibody responses at higher levels in mice boosted with TCV, with the rate of fall in IgG titres induced to Vi-PS being greater than for TCV. Therefore, Vi-specific IgM or IgG are independently capable of protecting from infection and any superior protection from vaccination with TCV in adults may relate to responses being able to persist better rather than from differences in the antibody isotypes induced. These findings suggest that enhancing our understanding of how responses to vaccines are maintained may inform on how to maximize protection afforded by conjugate vaccines against encapsulated pathogens such as S . Typhi.

  • Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals

    by Sian Faustini, Adrian Shields, Gemma Banham, Nadezhda Wall, Saly Al-Taei, Chloe Tanner, Zahra Ahmed, Elena Efstathiou, Neal Townsend, Margaret Goodall, et al.


  • SARS‐CoV‐2‐specific IgG1/IgG3 but not IgM in children with Pediatric Inflammatory Multi‐System Syndrome

    by Marisol Perez‐Toledo, Sian E. Faustini, Sian E. Jossi, Adrian M. Shields, Edith Marcial‐Juarez, Hari Krishnan Kanthimathinathan, Joel D. Allen, Yasunori Watanabe, Margaret Goodall, Benjamin E. Willcox, et al.

    There is a low rate of symptomatology associated with SARS‐CoV‐2 infection in children and a substantially lower risk of death than in adults1. Nevertheless, in rare cases some children present with features of a multisystem inflammatory syndrome with overlapping features of Kawasaki disease and toxic shock syndrome2,3.


  • Open Access

    Serology confirms SARS-CoV-2 infection in PCR-negative children with Paediatric Inflammatory Multi-System Syndrome

    by Marisol Perez-Toledo, Sian Faustini, Sian Jossi, Adrian Shields, Edith Marcial-Juarez, Hari Krishnan Kanthimathinathan, Joel Allen, Yasunori Watanabe, Margaret Goodall, Benjamin Willcox, et al.

    A document by Marisol Perez-Toledo, written on Authorea.


  • Open Access

    Mice Deficient in T-bet Form Inducible NO Synthase–Positive Granulomas That Fail to Constrain Salmonella

    by Marisol Perez-Toledo, Nonantzin Beristain-Covarrubias, William M. Channell, Jessica R. Hitchcock, Charlotte N. Cook, Ruth E Coughlan, Saeeda Bobat, Nicholas D. Jones, Kyoko Nakamura, Ewan A Ross, et al.

    Clearance of intracellular infections caused by Salmonella Typhimurium (STm) requires IFN-γ and the Th1-associated transcription factor T-bet. Nevertheless, whereas IFN-γ−/− mice succumb rapidly to STm infections, T-bet−/− mice do not. In this study, we assess the anatomy of immune responses and the relationship with bacterial localization in the spleens and livers of STm-infected IFN-γ−/− and T-bet−/− mice. In IFN-γ−/− mice, there is deficient granuloma formation and inducible NO synthase (iNOS) induction, increased dissemination of bacteria throughout the organs, and rapid death. The provision of a source of IFN-γ reverses this, coincident with subsequent granuloma formation and substantially extends survival when compared with mice deficient in all sources of IFN-γ. T-bet−/− mice induce significant levels of IFN-γ− after challenge. Moreover, T-bet−/− mice have augmented IL-17 and neutrophil numbers, and neutralizing IL-17 reduces the neutrophilia but does not affect numbers of bacteria detected. Surprisingly, T-bet−/− mice exhibit surprisingly wild-type–like immune cell organization postinfection, including extensive iNOS+ granuloma formation. In wild-type mice, most bacteria are within iNOS+ granulomas, but in T-bet−/− mice, most bacteria are outside these sites. Therefore, Th1 cells act to restrict bacteria within IFN-γ–dependent iNOS+ granulomas and prevent dissemination. Key Points T-bet−/− mice induce significant IFN-γ responses after Salmonella infection. Infection of T-bet−/− mice enhances nonprotective Th17/neutrophil responses. iNOS+ granulomas that fail to constrain Salmonella are induced in T-bet−/− mice.